As multi-agonists secure approvals, reimbursement authorities may reward stronger risk-reduction profiles, underpinning sustained GLP-1 diabetes drugs market expansion in the latter half of the decade
It may be mixed with a substance known as a buffering agent or excipient to maintain its stability, purity, and the correct pH for storage and administration
Yu Pan, C
The first two reports, both 4 week studies in drug nave patients with relatively mild T2DM, showed that DPP-4 inhibition was well-tolerated in humans and was associated with significantly lower fasting and meal-related glucose concentrations (32, 33)
For more information about addiction and related topics, check out our Glossary of Addiction Treatment Terms.
Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Alimova IN, Rosenfeld SV, Zavarzina NY, Semenchenko AV, Yashin AI